Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-10-31
1991-06-04
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3150
Patent
active
050214160
ABSTRACT:
Certain (2-imidazolin-2-ylamino) quinoxalines are disclosed. Such quinoxalines reduce or maintain intraocular pressure when administered directly to the eye of a mammal.
REFERENCES:
patent: 3890319 (1975-06-01), Danielewicz
Burke et al. Current Eye Research; Sep. 5 (9): 665-76 (1986).
Mittag. Annals of Ophthalmology 1983; 15(3): 201-202.
Renal Effects of Selective Alpha-1 and Alpha-2 Adrenoceptor Agonists in Conscious, Normotensive Rats; Miklos Gellai & Robert R. Ruffolo, Jr.
Selective Alpha-2 Adrenoceptor Agonists Alter Fluid and Electrolyte Transport in Mammalian Small Intestine; Joseph D. Fondacaro, David Kolpak & Gerald P. McCafferty.
Ocular Effects of a Relatively Selective Alpha-2 Agonist (UK-14, 304-18) in Cats, Rabbits and Monkeys; J. A. Burke and D. E. Potter.
Alpha-2 Adrenergic Modulation of Norepinephrine Secretion in the Perfused Rabbit Iris-Ciliary Body; James E. Jumblatt, John G. H. Liu & Ginnie T. North.
Ocular Effects of Selective Alpha-Adrenergic Agents: A New Drug Paradox? Tom Mittag, Ph.D.
Mechanism of Alpha-2-Adrenoceptor Agonist-Induced Diuresis Miklos Gellai & Richard M. Edwards.
Clonidine and Some Bridge Analogues; Cardiovascular Effects and Nuclear Magnetic Resonance Data (H/C); Pieter B.M.W.M. Timmermans & Pieter A. van Zwieten.
Alpha-2-Adrenergic Receptors Accelerate Na/H Exchange in Neuroblastoma X Glioma Cells* Lori L. Isom; E. J. Cragoe, Jr.; and Lee E. Limbird.
Clonidine: New Research in Psychotropic Drug Pharmacology; Stuart Fielding, Harbans Lal.
Clonidine and Related Compounds; Bevyn Jarrott.
Alpha-2 Adrenergic Agonists: A Newer Class of Antidiarrheal Drug Gastroenterology 1986:91:769-75.
Allergan Inc.
Fay Zohreh A.
Friedman Stanley J.
Peterson Gordon L.
Uxa, Jr. Frank J.
LandOfFree
Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026521